Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Jiang

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Molecular Therapy. Nucleic Acids|August 29, 2022
Self-assembling short immunostimulatory duplex RNAs with broad-spectrum antiviral activityLonglong Si, Haiqing Bai, Crystal Yuri Oh, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironmentEric A Smith, Rachel L Belote, Nelly M Cruz, et al.
Nature Medicine|September 14, 2014
An extracorporeal blood-cleansing device for sepsis therapyJoo H Kang, Michael Super, Chong Wing Yung, et al.
Frontiers in Pharmacology|November 11, 2021
Enteric Coronavirus Infection and Treatment Modeled With an Immunocompetent Human Intestine-On-A-ChipAmir Bein, Seongmin Kim, Girija Goyal, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2024
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironmentEric A Smith, Rachel L Belote, Nelly M Cruz, et al.
The British Journal of Dermatology|October 28, 2025
Subclinical Fields of BRAF V600E-Mutant Melanocytes Populate Human Skin and Are Enriched Around Melanoma and NaeviKatie J Lee, Yung-Ching Kao, Amanda Jiang, et al.
The Journal of Clinical Investigation|October 24, 2017
Small GTPase ARF6 controls VEGFR2 trafficking and signaling in diabetic retinopathyWeiquan Zhu, Dallas S Shi, Jacob M Winter, et al.
Nature Biomedical Engineering|March 12, 2026
DNA origami vaccine nanoparticles improve humoral and cellular immune responses to infectious diseasesYang C Zeng, Olivia J Young, Qiancheng Xiong, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated MelanomaMona Foth, Wontak Kim, Kayla T O'Toole, et al.
Nature Biomedical Engineering|February 14, 2020
Author Correction: On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiologyDavid B Chou, Viktoras Frismantas, Yuka Milton, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Molecular Therapy. Nucleic Acids|August 29, 2022
Self-assembling short immunostimulatory duplex RNAs with broad-spectrum antiviral activityLonglong Si, Haiqing Bai, Crystal Yuri Oh, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironmentEric A Smith, Rachel L Belote, Nelly M Cruz, et al.
Nature Medicine|September 14, 2014
An extracorporeal blood-cleansing device for sepsis therapyJoo H Kang, Michael Super, Chong Wing Yung, et al.
Frontiers in Pharmacology|November 11, 2021
Enteric Coronavirus Infection and Treatment Modeled With an Immunocompetent Human Intestine-On-A-ChipAmir Bein, Seongmin Kim, Girija Goyal, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2024
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironmentEric A Smith, Rachel L Belote, Nelly M Cruz, et al.
The British Journal of Dermatology|October 28, 2025
Subclinical Fields of BRAF V600E-Mutant Melanocytes Populate Human Skin and Are Enriched Around Melanoma and NaeviKatie J Lee, Yung-Ching Kao, Amanda Jiang, et al.
The Journal of Clinical Investigation|October 24, 2017
Small GTPase ARF6 controls VEGFR2 trafficking and signaling in diabetic retinopathyWeiquan Zhu, Dallas S Shi, Jacob M Winter, et al.
Nature Biomedical Engineering|March 12, 2026
DNA origami vaccine nanoparticles improve humoral and cellular immune responses to infectious diseasesYang C Zeng, Olivia J Young, Qiancheng Xiong, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated MelanomaMona Foth, Wontak Kim, Kayla T O'Toole, et al.
Nature Biomedical Engineering|February 14, 2020
Author Correction: On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiologyDavid B Chou, Viktoras Frismantas, Yuka Milton, et al.
Pageof 6